SELLAS Life Sciences Group, Inc. (SLS) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $100.0K | -50.0% |
| 2021 | $200.0K | — |
| 2020 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $100.0K | -50.0% |
| 2021 | $200.0K | — |
| 2020 | $0 | — |